Related Experiment Video
Updated: Jul 19, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a
Laura A Grutters1, Imke Christiaans2
1Department of Genetics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30.001, Groningen, 9700 RB, The Netherlands.
Insights
Cascade genetic counseling and testing for inherited cardiovascular diseases show limited long-term uptake among at-risk relatives. Further research into barriers, including health system issues, is needed to improve participation rates.
Area of Science:
- Cardiovascular Genetics
- Medical Genetics
- Public Health
Background:
- Inherited cardiovascular diseases (ICDs) affect 1-2% of the global population.
- These include familial hypercholesterolemia, cardiomyopathies, and arrhythmia syndromes.
- Cascade genetic counseling and testing are valuable due to available preventive measures and treatments.
Purpose of the Study:
- To review the uptake of cascade genetic counseling and testing in ICDs.
- To identify barriers impeding at-risk relatives from seeking genetic counseling and testing.
- To propose future research directions for optimizing uptake.
Main Methods:
- Review of academic literature on cascade genetic counseling and testing in ICDs.
- Analysis of factors influencing uptake rates among at-risk relatives.
- Identification of knowledge, attitudinal, social, and practical barriers.
Main Results:
- Family-mediated cascade genetic counseling leads to ~40% uptake one year post-proband identification, with long-term uptake remaining incomplete.
- Previous interventions focusing on information dissemination have had minimal impact on uptake.
- Significant uptake improvement was observed in familial hypercholesterolemia with reduced health-system barriers.
Conclusions:
- Current cascade genetic counseling and testing strategies have suboptimal long-term uptake.
- Understanding the complex interplay of barriers in decision-making is crucial.
- Further research on health-system-related barriers is essential for developing effective interventions to optimize genetic counseling and testing uptake.
Abstract:
Inherited cardiovascular diseases cover the inherited cardiovascular disease familial hypercholesterolemia and inherited cardiac diseases, like inherited cardiomyopathies and inherited arrhythmia syndromes. Cascade genetic counseling and testing in inherited cardiovascular diseases have had three decades of academic attention. Inherited cardiovascular diseases affect around 1-2% of the population worldwide and cascade genetic counseling and testing are considered valuable since preventive measures and/or treatments are available. Cascade genetic counseling via a family-mediated approach leads to an uptake of genetic counseling and testing among at-risk relatives of around 40% one year after identification of the causal variant in the proband, with uptake remaining far from complete on the long-term. These findings align with uptake rates among relatives at-risk for other late onset medically actionable hereditary diseases, like hereditary cancer syndromes. Previous interventions to increase uptake have focused on optimizing the process of informing relatives through the proband and on contacting relatives directly. However, despite successful information dissemination to at-risk relatives, these approaches had little or no effect on uptake. The limited research into the barriers that impede at-risk relatives from seeking counseling has revealed knowledge, attitudinal, social and practical barriers but it remains unknown how these factors contribute to the decision-making process for seeking counseling in at-risk relatives. A significant effect on uptake of genetic testing has only been reached in the setting of familial hypercholesterolemia, where active information provision was accompanied by a reduction of health-system-related barriers. We propose that more research is needed on barriers -including health-system-related barriers- and how they hinder counseling and testing in at-risk relatives, so that uptake can be optimized by (adjusted) interventions.
Related Concept Videos
Pedigree Analysis
Pedigree Analysis
Pharmacogenomics: Identification of New Drug Targets
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy

